Tara N. Palmore

George Washington University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

David K. Henderson

National Institutes of Health

John P. Dekker

National Institute of Allergy and Infectious Diseases

David J. Weber

University of North Carolina Health Care

Angela V. Michelin

National Institutes of Health

Karen M. Frank

National Institutes of Health Clinical Center

Anna F. Lau

National Institutes of Health

Michael Klompas

Harvard Pilgrim Health Care

David P. Calfee

Weill Cornell Medicine

Julia A. Segre

National Institutes of Health

Chanu Rhee

Harvard University

Cooperative Institutions

New York Proton Center

2,396

Communities In Schools of Orange County

2,256

Oregon Medical Research Center

2,203

Lindsay Unified School District

2,169

University of Pittsburgh

1,442

Manhattan Institute for Policy Research

1,353

Museum of Heilongjiang Province

480

National Institutes of Health

305

Engineering Associates (United States)

273

University of Chicago

269

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

ICE volume 43 issue 3 Cover and Front matter

Infection Control and Hospital Epidemiology (2022)

Marya D. Zilberberg Brian H. Nathanson Laura Puzniak Andrew F. Shorr Blaine Kenaa

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Front cover

10.1017/ice.2022.74

Cite

Citations (0)

ICE volume 45 issue 2 Cover and Front matter

Infection Control and Hospital Epidemiology (2024)

Alexander Sundermann Waleed Javaid Andie S. Lee Leanne Dolan Frances Jenkins

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Front cover

10.1017/ice.2024.17

Cite

Citations (0)

Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus—United States, May 2013–August 2016

American Journal of Transplantation (2016)

Snigdha Vallabhaneni Alexander J. Kallen Sharon Tsay Nancy A. Chow Rory M. Welsh

November 11, 2016/65(44);1234–1237.What is already known about this topic?Candida auris is an emerging pathogenic fungus that has been reported from at least a dozen countries on four continents during 2009–2015. The organism is difficult to identify using traditional biochemical methods, some isolates have been found to be resistant to all three major classes of antifungal medications, and C. auris has caused health care–associated outbreaks.What is added by this report?This is the first description of C. auris cases in the United States. C. auris appears to have emerged in the United States only in the last few years, and U.S. isolates are related to isolates from South America and South Asia. Evidence from U.S. case investigations suggests likely transmission of the organism occurred in health care settings.What are the implications for public health practice?It is important that U.S. laboratories accurately identify C. auris and for health care facilities to implement recommended infection control practices to prevent the spread of C. auris. Local and state health departments and CDC should be notified of possible cases of C. auris and of isolates of C. haemulonii and Candida spp. that cannot be identified after routine testing. November 11, 2016/65(44);1234–1237. What is already known about this topic? Candida auris is an emerging pathogenic fungus that has been reported from at least a dozen countries on four continents during 2009–2015. The organism is difficult to identify using traditional biochemical methods, some isolates have been found to be resistant to all three major classes of antifungal medications, and C. auris has caused health care–associated outbreaks. What is added by this report? This is the first description of C. auris cases in the United States. C. auris appears to have emerged in the United States only in the last few years, and U.S. isolates are related to isolates from South America and South Asia. Evidence from U.S. case investigations suggests likely transmission of the organism occurred in health care settings. What are the implications for public health practice? It is important that U.S. laboratories accurately identify C. auris and for health care facilities to implement recommended infection control practices to prevent the spread of C. auris. Local and state health departments and CDC should be notified of possible cases of C. auris and of isolates of C. haemulonii and Candida spp. that cannot be identified after routine testing.

Candida auris

Dozen

10.1111/ajt.14121

Cite

Citations (217)

Universal decolonization was better than MRSA screening and isolation for preventing nosocomial ICU infections

Annals of Internal Medicine (2013)

Brooke K. Decker Tara N. Palmore

Source Citation Huang SS, Septimus E, Kleinman K, et al; CDC Prevention Epicenters Program and AHRQ DECIDE Network and Healthcare-Associated Infections Program. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368:2255-65. 23718152

Isolation

10.7326/0003-4819-159-6-201309170-02004

Cite

Citations (2)

SHEA Guideline for Management of Healthcare Workers Who Are Infected with Hepatitis B Virus, Hepatitis C Virus, and/or Human Immunodeficiency Virus

Carolina Digital Repository (University of North Carolina at Chapel Hill) (2010)

David K. Henderson Louise M. Dembry Neil O. Fishman Christine Grady Tammy Lundstrom

Guideline

Hepatitis virus

10.17615/fx23-7459

Cite

Citations (0)

43: DIFFICULT-TO-TREAT RESISTANCE IN GRAM-NEGATIVE BACTEREMIA AMONG ICU INPATIENTS AT 162 U.S. HOSPITALS

Critical Care Medicine (2017)

Sameer S. Kadri Yi Ling Lai Alicen B. Spaulding Emily Ricotta D. Rebecca Prevots

Kadri, Sameer; Lai, Yi Ling; Spaulding, Alicen; Ricotta, Emily; Prevots, D. Rebecca; Dekker, John; Palmore, Tara; Rhee, Chanu; Klompas, Michael; Powers, John III; Suffredini, Anthony; Hooper, David; Fridkin, Scott; Danner, Robert; Adjemian, Jennifer Author Information

Bacteremia

Gram

10.1097/01.ccm.0000528098.52329.6a

Cite

Citations (1)

Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals

The Lancet Infectious Diseases (2020)

Sameer S. Kadri Yi Ling Lai Sarah Warner Jeffrey R. Strich Ahmed Babiker

Bacteremia

Blood Culture

10.1016/s1473-3099(20)30477-1

Cite

Citations (193)

ICE volume 35 issue 3 Cover and Front matter

Infection Control and Hospital Epidemiology (2014)

Sorabh Dhar Ryan Marchaim Teena Tansek Adnan Chopra Ashish Yousuf

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Front cover

10.1017/s0899823x0019107x

Cite

Citations (0)

SHEA Guideline for Management of Healthcare Workers Who Are Infected with Hepatitis B Virus, Hepatitis C Virus, and/or Human Immunodeficiency Virus

Infection Control and Hospital Epidemiology (2010)

David K. Henderson Louise M. Dembry Neil O. Fishman Christine Grady Tammy Lundstrom

This guideline provides the updated recommendations of the Society for Healthcare Epidemiology of America (SHEA) regarding the management of healthcare providers who are infected with hepatitis B virus (HBV), hepatitis C virus (HCV), and/or the human immunodeficiency virus (HIV). For the reasons cited in the guideline, SHEA continues to recommend that, although some aspects of the approach to and administrative management of each of these infectious syndromes in healthcare providers are similar, separate management strategies for healthcare workers who are infected with these unrelated viruses remain appropriate. As we did in both prior iterations of this document, SHEA emphasizes the use of appropriate infection control procedures to minimize exposure of patients or providers to blood, emphasizes that transfers of blood from patients to providers and from providers to patients should be avoided, and recommends that infected healthcare providers should not be totally prohibited from participating in patient-care activities solely on the basis of a bloodborne pathogen infection. The types of procedures assessed by the panel as associated with an increased risk for provider-to-patient transmission of these pathogens are discussed in detail. For each pathogen, recommendations are graduated according to the relative viral load level of the infected provider (Tables 1 and 2). However, SHEA emphasizes that, because of the complexity of these cases, each such case will be slightly different from the next, and each should be independently considered in context.

Guideline

10.1086/650298

Cite

Citations (130)

Pooled Saliva Specimens for SARS-CoV-2 Testing

Journal of Clinical Microbiology (2020)

Bidisha Barat Sanchita Basu Das Valeria De Giorgi David K. Henderson Stacy L. Kopka

We evaluated saliva (SAL) specimens for SARS-CoV-2 reverse transcriptase PCR (RT-PCR) testing by comparison of 459 prospectively paired nasopharyngeal (NP) or midturbinate (MT) swabs from 449 individuals with the aim of using saliva for asymptomatic screening. Samples were collected in a drive-through car line for symptomatic individuals ( n = 380) and in the emergency department (ED) ( n = 69).

2019-20 coronavirus outbreak

Betacoronavirus

Sars virus

Coronavirus Infections

10.1128/jcm.02486-20

Cite

Citations (68)